Company Filing History:
4 out of 24 
4 out of 24 
4 out of 18 Years Active: 2022-2023
Title: Ann Siehoff - Innovator in Cell Therapy Automation
Introduction
Ann Siehoff is a prominent inventor based in Cologne, Germany. She has made significant contributions to the field of cell therapy automation, holding a total of four patents. Her work focuses on the development of automated methods for producing genetically modified immune cells, which are crucial for advancing medical treatments.
Latest Patents
Among her latest patents is the innovative "End-to-end cell therapy automation." This patent provides an automated method of producing genetically modified immune cells, including chimeric antigen receptor T (CAR T) cells, utilizing a fully-enclosed cell engineering system. This advancement is pivotal in streamlining the production process and enhancing the efficiency of cell therapies.
Career Highlights
Throughout her career, Ann has worked with notable companies such as Lonza Walkersville, Inc. and Lonza Cologne GmbH. Her experience in these organizations has allowed her to develop and refine her expertise in cell therapy automation, contributing to her success as an inventor.
Collaborations
Ann has collaborated with esteemed colleagues, including Yaling Shi and Erika McAfee. These partnerships have fostered innovation and have been instrumental in her research and development efforts.
Conclusion
Ann Siehoff's contributions to cell therapy automation exemplify her dedication to advancing medical technology. Her innovative patents and collaborative efforts position her as a key figure in the field, paving the way for future advancements in cell therapy.